11-77181589-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2_SupportingPM3_StrongPP4PP1
This summary comes from the ClinGen Evidence Repository: The c.2904G>T variant in MYO7A is a missense variant predicted to cause substitution of glutamic acid by aspartic acid at amino acid 968. The highest population minor allele frequency in gnomAD v2.1.1 is 0.0000064 (3/126898 alleles) in the European (non-Finnish) population, which is lower than the ClinGen Hearing Loss VCEP threshold (<0.00007) for PM2_Supporting, meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.563, which is neither above nor below the thresholds predicting a damaging or benign impact on MYO7A function. At least one patient with this variant displayed Usher syndrome (PP4, PMID:33089500). This variant has been detected in at least five individuals with Usher syndrome. Of those individuals, two were compound heterozygous for the variant and a pathogenic or likely pathogenic variant and presumed to be in trans (c.631A>G (p.S211G) and c.3719G>A (p.D1240Q)) and three of those were confirmed in trans by family testing and all of whom had different variants on the other allele (c.224dup (p.D75fs), c.487G>C (p.G163R), c.1189G>A (p.A397T); 2.5 PM3 points, PMID:25472526, 26969326, 33089500; ClinVar Variation ID: 43325, 43218, 553215) (PM3_Strong). The variant has been reported to segregate with Usher syndrome in three affected family members from one family (PP1; PMID:33089500). Another missense variant, c.2904G>C (p.E968D), in the same codon has been reported in a patient with Usher syndrome (PMID:27460420). However, this variant has not yet met the criteria to be classified as pathogenic or likely pathogenic by the ClinGen Hearing Loss VCEP (PM5 not met). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PM2_P, PP1, PP4, PM3_S (ClinGen Hearing Loss VCEP specifications version 2; 7/26/2022). LINK:https://erepo.genome.network/evrepo/ui/classification/CA278647/MONDO:0700087/005
Frequency
Consequence
NM_000260.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.2904G>T | p.Glu968Asp | missense_variant, splice_region_variant | Exon 23 of 49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.2904G>T | p.Glu968Asp | missense_variant, splice_region_variant | Exon 23 of 49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.2871G>T | p.Glu957Asp | missense_variant, splice_region_variant | Exon 24 of 50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.447G>T | p.Glu149Asp | missense_variant, splice_region_variant | Exon 3 of 29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.744G>T | splice_region_variant, non_coding_transcript_exon_variant | Exon 6 of 32 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000810 AC: 2AN: 247002Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134530
GnomAD4 exome AF: 0.0000514 AC: 75AN: 1460532Hom.: 0 Cov.: 33 AF XY: 0.0000509 AC XY: 37AN XY: 726474
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74306
ClinVar
Submissions by phenotype
not provided Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. This missense change has been observed in individuals with autosomal recessive Usher syndrome (PMID: 10930322, 15660226, 24199935, 25472526, 26969326). This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 968 of the MYO7A protein (p.Glu968Asp). This variant also falls at the last nucleotide of exon 23, which is part of the consensus splice site for this exon. This variant is present in population databases (rs111033233, gnomAD 0.003%). ClinVar contains an entry for this variant (Variation ID: 43196). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. -
The E968D missense variant in the MYO7A gene has been reported in association with Usher syndrome type I (Bharadwaj et al., 2000; Jacobson et al., 2009). In both reports, E968D was identified in a patient who also harbored a second missense variant. The c.2904 G>T pathogenic variant changes the last nucleotide in exon 23 of the MYO7A gene, which might affect the donor splice site and result in exons skipping. Splice prediction algorithms indicate that the E968D variant destroys the donor splice site. E968D was not observed in approximately 6,200 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, we interpret E968D to be a pathogenic variant. -
Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
- -
Usher syndrome type 1B Pathogenic:1
The c.2904G>T variant in MYO7A is a missense variant predicted to cause substitution of glutamic acid by aspartic acid at amino acid 968. The highest population minor allele frequency in gnomAD v2.1.1 is 0.0000064 (3/126898 alleles) in the European (non-Finnish) population, which is lower than the ClinGen Hearing Loss VCEP threshold (<0.00007) for PM2_Supporting, meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.563, which is neither above nor below the thresholds predicting a damaging or benign impact on MYO7A function. At least one patient with this variant displayed Usher syndrome (PP4, PMID: 33089500). This variant has been detected in at least five individuals with Usher syndrome. Of those individuals, two were compound heterozygous for the variant and a pathogenic or likely pathogenic variant and presumed to be in trans (c.631A>G (p.S211G) and c.3719G>A (p.D1240Q)) and three of those were confirmed in trans by family testing and all of whom had different variants on the other allele (c.224dup (p.D75fs), c.487G>C (p.G163R), c.1189G>A (p.A397T); 2.5 PM3 points, PMID: 25472526, 26969326, 33089500; ClinVar Variation ID: 43325, 43218, 553215) (PM3_Strong). The variant has been reported to segregate with Usher syndrome in three affected family members from one family (PP1; PMID:33089500). Another missense variant, c.2904G>C (p.E968D), in the same codon has been reported in a patient with Usher syndrome (PMID:27460420). However, this variant has not yet met the criteria to be classified as pathogenic or likely pathogenic by the ClinGen Hearing Loss VCEP (PM5 not met). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PM2_P, PP1, PP4, PM3_S (ClinGen Hearing Loss VCEP specifications version 2; 7/26/2022). -
Usher syndrome type 1;C1832475:Autosomal dominant nonsyndromic hearing loss 11;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
- -
Rare genetic deafness Pathogenic:1
The p.Glu968Asp variant in MYO7A has been identified at least 7 individuals with clinical features of Usher syndrome, including 1 homozygote and 5 compound hete rozygotes (Bharadwaj 2000, Ouyang 2005, Jacobson 2008, Le Quesne 2012, Bujakowsk a 2014, Zhao 2015, Sloan-Heggen 2016, Bonnet 2016, LMM unpublished data). This v ariant has been identified in 4/125720 European chromosomes by the Genome Aggreg ation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs111033233). Al though this variant has been seen in the general population, its frequency is lo w enough to be consistent with a recessive carrier frequency. The p.Glu968Asp va riant is located in the last base of the exon, which is part of the 5? splice re gion and computational tools predict altered splicing. In summary, this variant meets criteria to be classified as pathogenic for Usher syndrome in an autosomal recessive manner based upon proband counts, frequency in controls, and predicte d impact on protein. ACMG/AMP Criteria applied: PM3_VeryStrong, PS4, PM2, PVS1_M oderate. -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at